Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5577798 | Cor et Vasa | 2016 | 5 Pages |
Abstract
High residual platelet reactivity (HRPR) in patients taking dual antiplatelet therapy (DAPT) is closely associated with serious ischaemic events, particularly in-stent thrombosis. Literature reports many cases of patients taking the combination of acetylsalicylic acid and clopidogrel with early in-stent thrombosis and the detection of high residual platelet reactivity, but cases in patients using a combination of new antiplatelet drugs are rare. The following case report presents the case of a patient with early in-stent thrombosis in whom HRPR was detected while he was on prasugrel therapy and describes the subsequent management of the complication.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martin HajÅ¡l, Pavel SedloÅ, Miroslav Zavoral, Martin Malý,